Hepion Pharmaceuticals Shares Are Trading Lower After the Company Announced That It Began Wind-down Activities in Its Phase 2b "ASCEND-NASH Trial.
Hepion Pharmaceuticals Shares Are Trading Lower After the Company Announced That It Began Wind-down Activities in Its Phase 2b "ASCEND-NASH Trial.
Hepion Pharmicals宣布在2b阶段 “ASCEND-NASH” 试验中开始清盘活动后，该公司股价走低。
Hepion Pharmaceuticals Shares Are Trading Lower After the Company Announced That It Began Wind-down Activities in Its Phase 2b "ASCEND-NASH Trial.
Hepion Pharmicals宣布在2b阶段 “ASCEND-NASH” 试验中开始清盘活动后，该公司股价走低。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。